Document is current
Any future updates will be listed below
-
Authors
Antón-Bolaños, Noelia https://orcid.org/0000-0001-6590-4316
Faravelli, Irene
Faits, Tyler https://orcid.org/0000-0002-7524-6166
Andreadis, Sophia
Kastli, Rahel
Trattaro, Sebastiano
Adiconis, Xian
Wei, Anqi
Sampath Kumar, Abhishek https://orcid.org/0000-0001-7918-6706
Di Bella, Daniela J. https://orcid.org/0000-0001-6141-3704
Tegtmeyer, Matthew https://orcid.org/0000-0002-9032-8207
Nehme, Ralda https://orcid.org/0000-0001-7215-3311
Levin, Joshua Z. https://orcid.org/0000-0002-0170-3598
Regev, Aviv
Arlotta, Paola https://orcid.org/0000-0003-2184-2277
- License Information
-
More Information
Article History
Received: 11 July 2023
Accepted: 17 May 2024
First Online: 26 June 2024
Competing interests
: P.A. is a scientific advisory board member at Foresite Labs, CNSII, and is a co-founder and scientific advisory board member of Vesalius Therapeutics. A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and, until 31 August 2020, was a scientific advisory board member of Syros Pharmaceuticals, Neogene Therapeutics, Asimov and Thermo Fisher Scientific. From 1 August 2020, A.R. has been an employee of Genentech and has equity in Roche.
